Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Angiogenin, FGF-α, and IL-36β have higher expression levels in aqueous humor of nAMD patients in comparison to cataract patients

Fig. 1

Aqueous humor cytokines concentrations in patients with cataract or nAMD. The nAMD patients received three consecutive monthly ranibizumab injections. Values represent mean ± SD of aqueous levels of cytokines concentrations in 20 cataract or 20 nAMD patients at baseline (M0), month 1 (M1), and month 2 (M2). Aqueous levels of angiogenin, FGF-α, and IL-36β in nAMD patients were significantly higher than in cataract patients, both before and after injections of ranibizumab. Aqueous VEGF-A and PlGF in nAMD patients were significantly reduced after two consecutive monthly ranibizumab injections. *P < 0.05, **P < 0.01, ***P < 0.001 vs. cataract group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. nAMD baseline group

Back to article page